gemfibrozil has been researched along with Auricular Fibrillation in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of this study was to investigate whether the PPARalpha activator gemfibrozil prevents or delays the development of AF in patients with coronary heart disease." | 9.14 | Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial. ( Adabag, AS; Al Aloul, B; Bertog, S; Bloomfield, HE; Collins, D; Mithani, S, 2009) |
| " The objective of this study was to investigate whether the PPARalpha activator gemfibrozil prevents or delays the development of AF in patients with coronary heart disease." | 5.14 | Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial. ( Adabag, AS; Al Aloul, B; Bertog, S; Bloomfield, HE; Collins, D; Mithani, S, 2009) |
| " Regardless of the fibric acid derivative chosen, an empiric dosage reduction of 20% and close INR monitoring are warranted in patients receiving warfarin." | 2.45 | Interaction between gemfibrozil and warfarin: case report and review of the literature. ( Dixon, DL; Williams, VG, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adabag, AS | 1 |
| Mithani, S | 1 |
| Al Aloul, B | 1 |
| Collins, D | 1 |
| Bertog, S | 1 |
| Bloomfield, HE | 1 |
| Dixon, DL | 1 |
| Williams, VG | 1 |
1 review available for gemfibrozil and Auricular Fibrillation
| Article | Year |
|---|---|
Interaction between gemfibrozil and warfarin: case report and review of the literature.
Topics: Anticoagulants; Atrial Fibrillation; Drug Interactions; Follow-Up Studies; Gemfibrozil; Humans; Hypo | 2009 |
1 trial available for gemfibrozil and Auricular Fibrillation
| Article | Year |
|---|---|
Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial.
Topics: Aged; Atrial Fibrillation; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Double-Blind Method | 2009 |